Glycopeptide Immunogen Platform
Infectious Disease (e.g., HIV), Cancer
Pre-clinicalActive
Key Facts
Indication
Infectious Disease (e.g., HIV), Cancer
Phase
Pre-clinical
Status
Active
Company
About Chemitope Glycopeptide
Chemitope Glycopeptide is a private, pre-clinical stage biotech founded in 2016, focusing on the synthesis of complex glycopeptides. Its core technology enables atomic-level control for producing homogeneous glycopeptides at scale, supporting both internal vaccine programs and external partners in academia and pharma. The company is led by CEO Baptiste Aussedat, an expert in glycopeptide chemistry, and its work is validated by high-profile publications and the production of materials for a Phase I clinical trial.
View full company profile